A central role of eNOS in the protective effect of wine against metabolic syndrome

Cell Biochemistry and Function - Tập 24 Số 4 - Trang 291-298 - 2006
Federico Leighton1, Soledad Miranda‐Rottmann, Inés Urquiaga
1Laboratorio de Nutrición Molecular, Facultad de Ciencias Biológicas, Universidad Católica de Chile, Chile. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Rimm, 1999, BMJ, 319, 1523, 10.1136/bmj.319.7224.1523

Gong, 2003, J Clin Invest, 111, 1579, 10.1172/JCI16777

Matthews, 2001, Stroke, 32, 1104, 10.1161/01.STR.32.5.1104

Mardones, 2002, J Nutr, 132, 443, 10.1093/jn/132.3.443

Landmesser, 2003, J Clin Invest, 111, 1201, 10.1172/JCI200314172

Renaud, 1992, Lancet, 339, 1523, 10.1016/0140-6736(92)91277-F

Booyse, 2001, Thromb Haemost, 86, 517, 10.1055/s-0037-1616080

, , . Moderate alcohol increases clot lysis in vivo in a mouse model by increasing t-PA and u-PA and decreasing PAI–1 expression. American Heart Association Scientific Sessions. Orlando, FL November 2003; 9–12.

Tabengwa, 2002, Alcohol Clin Exp Res, 26, 1121, 10.1111/j.1530-0277.2002.tb02647.x

Pinelli, 2003, Cardiovasc Drugs Ther, 17, 15, 10.1023/A:1024299523852

Cook, 2003, Swiss Med Wkly, 133, 360

de Gaetano, 2002, Ann N Y Acad Sci, 957, 174, 10.1111/j.1749-6632.2002.tb02915.x

Wollny, 1999, Br J Pharmacol, 127, 747, 10.1038/sj.bjp.0702586

Ruf, 2004, Biol Res, 37, 209, 10.4067/S0716-97602004000200006

Danielewski, 2005, Thromb Haemost, 93, 319, 10.1160/TH04-09-0582

Leikert, 2002, Circulation, 106, 1614, 10.1161/01.CIR.0000034445.31543.43

Wallerath, 2002, Circulation, 106, 1652, 10.1161/01.CIR.0000029925.18593.5C

Martin, 2002, Br J Pharmacol, 135, 1579, 10.1038/sj.bjp.0704603

Wallerath, 2005, Nitric Oxide, 12, 97, 10.1016/j.niox.2004.12.004

Kawashima, 2004, Endothelium, 11, 99, 10.1080/10623320490482637

Corder, 2001, Nature, 414, 863, 10.1038/414863a

Venkov, 1999, Thromb Haemost, 81, 638, 10.1055/s-0037-1614538

Cuevas, 2000, Lipids, 35, 143, 10.1007/BF02664763

Leighton, 1999, Drugs Exp Clin Res, 25, 133

Sies, 2005, Am J Clin Nutr, 81, 304s, 10.1093/ajcn/81.1.304S

Shimada, 1999, Lancet, 354, 1002, 10.1016/S0140-6736(99)03478-9

Plotnick, 1997, JAMA, 278, 1682, 10.1001/jama.1997.03550200058032

Stocker, 2004, Physiol Rev, 84, 1381, 10.1152/physrev.00047.2003

De Caterina, 2000, Curr Opin Lipidol, 11, 9, 10.1097/00041433-200002000-00003

Parks, 2002, Ann N Y Acad Sci, 957, 115, 10.1111/j.1749-6632.2002.tb02910.x

Reaven, 1988, Diabetes, 37, 1595, 10.2337/diab.37.12.1595

Grundy, 2004, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6

Kraja, 2005, Nutr Metab (Lond), 2, 2, 10.1186/1743-7075-2-2

Bell, 2000, Diabetes Care, 23, 1630, 10.2337/diacare.23.11.1630

Reaven, 2005, Cell Metabolism, 1, 9, 10.1016/j.cmet.2004.12.001

Goude, 2002, Clin Sci (Lond), 102, 345, 10.1042/cs1020345

Dixon, 2002, Obes Res, 10, 245, 10.1038/oby.2002.33

Wannamethee, 2004, Obes Res, 12, 1386, 10.1038/oby.2004.175

Vadstrup, 2003, Int J Obes Relat Metab Disord, 27, 238, 10.1038/sj.ijo.802203

Strobel, 2005, Biochem J, 386, 471, 10.1042/BJ20040703

Rosell, 2003, Eur J Clin Nutr, 57, 227, 10.1038/sj.ejcn.1601548

Djousse, 2004, Obes Res, 12, 1375, 10.1038/oby.2004.174

Freiberg, 2004, Diabetes Care, 27, 2954, 10.2337/diacare.27.12.2954

Furukawa, 2004, J Clin Invest, 114, 1752, 10.1172/JCI21625

Cook, 2004, Diabetes, 53, 2067, 10.2337/diabetes.53.8.2067

Monti, 2003, Diabetes, 52, 1270, 10.2337/diabetes.52.5.1270

Fernandez, 2004, Thromb Haemost, 92, 413, 10.1160/TH04-02-0103

Chrysohoou, 2004, Am Heart J, 148, 733, 10.1016/j.ahj.2004.04.022

Liu, 2005, J Am Soc Nephrol, 16, 1085, 10.1681/ASN.2004100817

Matfin, 2005, Curr Diab Rep, 5, 64, 10.1007/s11892-005-0070-8

Bivalacqua, 2000, Trends Pharmacol Sci, 21, 484, 10.1016/S0165-6147(00)01587-X

Wilson, 2004, Science, 306, 1190, 10.1126/science.1102521

Gurnell, 2003, J Clin Endocrinol Metab, 88, 2412, 10.1210/jc.2003-030435

Hegele, 2005, Int J Obes Relat Metab Disord, 29, s31, 10.1038/sj.ijo.0802911

Calnek, 2003, Arterioscler Thromb Vasc Biol, 23, 52, 10.1161/01.ATV.0000044461.01844.C9

Cho, 2004, J Biol Chem, 279, 2499, 10.1074/jbc.M309451200

Green, 2004, J Physiol, 561, 1, 10.1113/jphysiol.2004.068197

Fukai, 2000, J Clin Invest, 105, 1631, 10.1172/JCI9551

Dimmeler, 2003, Circulation, 107, 3118, 10.1161/01.CIR.0000074244.82874.A0

Hambrecht, 2003, Circulation, 107, 3152, 10.1161/01.CIR.0000074229.93804.5C

Momken, 2004, Am J Physiol Heart Circ Physiol, 287, h914, 10.1152/ajpheart.00651.2003

Hayden, 2003, Cardiovasc Diabetol, 2, 2, 10.1186/1475-2840-2-2

Badia, 2004, Am J Clin Nutr, 80, 225, 10.1093/ajcn/80.1.225

Estruch, 2004, Atherosclerosis, 175, 117, 10.1016/j.atherosclerosis.2004.03.006

Sjoholm, 2005, Lancet, 365, 610, 10.1016/S0140-6736(05)17912-4

Urakawa, 2003, J Clin Endocrinol Metab, 88, 4673, 10.1210/jc.2003-030202

Stoclet, 1999, J Physiol Pharmacol, 50, 535

Benito, 2002, Br J Pharmacol, 135, 910, 10.1038/sj.bjp.0704534

Hollenberg, 2003, Curr Hypertens Rep, 5, 287

Esposito, 2004, JAMA, 292, 1440, 10.1001/jama.292.12.1440